AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy

AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy

Abstract Background An unexpected recurrence of hepatocellular carcinoma (HCC) sometimes occurs in patients with hepatitis C virus (HCV) after treatment with direct-acting antivirals (DAAs). However, the characteristics of patients with HCC recurrence may differ depending on time after DAA treatment...

Full description

Bibliographic Details
Main Authors: Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Norio Horiike, Yoshinori Tanaka, Fujimasa Tada, Yoshiyasu Kisaka, Seiji Nakanishi, Kazuhiko Yamauchi, Hironori Ochi, Atsushi Hiraoka, Sen Yagi, Atsushi Yukimoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Cancer
Subjects:
DAA
Time of recurrence
Renal function
Treatment history
Risk factor
Prediction
Online Access:https://doi.org/10.1186/s12885-021-08401-7

Internet

https://doi.org/10.1186/s12885-021-08401-7

Similar Items